Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

Andrew B. Lassman; Stephanie L. Pugh; Mark R. Gilbert; Kenneth D. Aldape; Sandrine Geinoz; Jan H. Beumer; Susan M. Christner; Ritsuko Komaki; Lisa M. DeAngelis; Rakesh Gaur; Emad Youssef; Henry Wagner; Minhee Won; Minesh P. Mehta

doi:10.1093/neuonc/nov011

Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

Andrew B. Lassman, Stephanie L. Pugh, Mark R. Gilbert, Kenneth D. Aldape, Sandrine Geinoz, Jan H. Beumer, Susan M. Christner, Ritsuko Komaki, Lisa M. DeAngelis, Rakesh Gaur, Emad Youssef, Henry Wagner, Minhee Won, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	17
DOIs	https://doi.org/10.1093/neuonc/nov011
State	Published - Jul 1 2015

Disciplines

Medicine and Health Sciences
Pathology
Immunology and Infectious Disease

Access to Document

10.1093/neuonc/nov011License: Unspecified

Cite this

@article{d04801da08e54fc78987ea6b9611a589,

title = "Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).",

author = "Lassman, \{Andrew B.\} and Pugh, \{Stephanie L.\} and Gilbert, \{Mark R.\} and Aldape, \{Kenneth D.\} and Sandrine Geinoz and Beumer, \{Jan H.\} and Christner, \{Susan M.\} and Ritsuko Komaki and DeAngelis, \{Lisa M.\} and Rakesh Gaur and Emad Youssef and Henry Wagner and Minhee Won and Mehta, \{Minesh P.\}",

note = "Neuro Oncol. 2015 Jul;17(7):992-8. doi: 10.1093/neuonc/nov011. Epub 2015 Mar 10. Clinical Trial, Phase II; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't",

year = "2015",

month = jul,

day = "1",

doi = "10.1093/neuonc/nov011",

language = "American English",

volume = "17",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

AU - Lassman, Andrew B.

AU - Pugh, Stephanie L.

AU - Gilbert, Mark R.

AU - Aldape, Kenneth D.

AU - Geinoz, Sandrine

AU - Beumer, Jan H.

AU - Christner, Susan M.

AU - Komaki, Ritsuko

AU - DeAngelis, Lisa M.

AU - Gaur, Rakesh

AU - Youssef, Emad

AU - Wagner, Henry

AU - Won, Minhee

AU - Mehta, Minesh P.

N1 - Neuro Oncol. 2015 Jul;17(7):992-8. doi: 10.1093/neuonc/nov011. Epub 2015 Mar 10. Clinical Trial, Phase II; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

PY - 2015/7/1

Y1 - 2015/7/1

UR - https://www.ncbi.nlm.nih.gov/pubmed/25758746

U2 - 10.1093/neuonc/nov011

DO - 10.1093/neuonc/nov011

M3 - Article

VL - 17

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).

Disciplines

Access to Document

Other files and links

Cite this